Hide Board Information

Show Board Information

Immunomedics Inc. IMMU

Board Mod: Add me as mod

Asst Mods:

Last Post: 09/15/2020 8:00:48 AM

Board Marks: 1

Posts Today: 0

Board Views Today: 47

Immunomedics Inc. (NASDAQ: IMMU)

Immunomedics is a New Jersey-based biopharmaceutical company primarily focused on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune and other serious diseases.

Company Website: http://www.immunomedics.com/

Immunomedics Inc. (NASDAQ: IMMU) Stock Message Board

1. IMMU Company Profile

    

2. IMMU Time & Sales

    

3. IMMU Recent News

    

4. IMMU Filings

    

5. IMMU Financials

    

6. IMMU Buy Rating

Create New Post View All Posts Board Mark Banned

Post

Subject

Author

Posted On

1

IMMU. climber & a candle.

PoemStone

07/20/2013 10:15:20 AM

Newer

Recent Articles

• Exploring Recent Developments in Australian Oilseeds Holdings
• bp's $7 Billion Investment: Paving the Way for Cleaner Energy
• Anixa Biosciences Expands Strategy with Bitcoin Investment
• Exciting Changes Ahead for McDonald's Value Menu in 2025
• Premarket Stock Highlights: Gains for Gap and Ross Stores
• Volkswagen Labour Vote Signals Approaching Strike Actions
• Zeta Global Under Investigation – What Investors Need to Know
• Charles Schwab Sets Stage for Spot Cryptocurrency Trading
• Revolutionizing Dispute Resolution with Innovative AI Technology
• Leadership Transformation at TDECU: Roland Hendricks Takes Over
• Future Growth Projections for the Supercapacitor Sector
• Humacyte Unveils Promising Phase 3 AV Access Trial Results
• Seed Treatment Market Growth Projection to $9.2 Billion
• New Partnership Aims to Boost Economic Growth and Jobs
• Verizon Updates Debt Tender Offers and Participation Dates
• BioXcel Therapeutics Secures $7 Million Through Public Offering
• EHang Holdings Limited Shares Surge Amid New Repurchase Program
• Cathie Wood on Bitcoin's Future: Opportunities and Predictions
• EQT Exeter Expands Portfolio with Class A Distribution Facilities
• Prospero Staff Capital Boosts Roadrunner’s Growth Potential
• Trulieve’s Leadership Boosts Confidence with Insider Share Purchases
• Exploring the Future of Australian Oilseeds Holdings Limited
• Aptose Biosciences Aims for $8 Million in Funding Through Offering
• ENDRA Life Sciences Achieves Nasdaq Compliance Milestone
• WTW Increases Share Buyback Program by $1 Billion Boost
• Applied Industrial Technologies' Strategic Acquisition of Hydradyne
• Johnson & Johnson's TREMFYA Undergoes FDA Evaluation for UC
• Sunshine Biopharma Enhances Generic Drug Offering with Ursodiol
• Nano Labs Launches Next-Gen Crypto Mining Chips for Efficiency
• Bitdeer Technologies Secures $360 Million Through Senior Notes
• Brokerages Favor December Rate Cut Despite Economic Strength
• Morgan Stanley Suggests Caution with Ermenegildo Zegna Stocks
• Swiss National Bank: Embracing Flexibility in Monetary Policy
• Market Perspectives on Trump's Potential Impact on Stocks
• Insights on Bitcoin's Surge and Its Key Market Players
• Exploring Semiconductor Stocks with Promising Dividend Growth
• Legal Action Looms as ASML Stock Dips Amid Lawsuit News
• Bitcoin's Surge Towards $100,000: Experts Weigh In on Future Impact
• Investigation into Quanterix Corporation and Its Securities Practices
• LyondellBasell Unveils New Leadership Transition in Finance
• Latest CIBC ETF Cash Distributions You Should Know About
• National Bank Investments Reveals Capital Gains for EVO ETF
• Reliance Global Reports Positive Adjusted EBITDA and Sales Growth
• Exploring Innovations of Australian Oilseeds Holdings Limited
• Kevin Krumm Joins Flex as New CFO: Strategic Shift Ahead
• Exploring the Market Potential of Australian Oilseeds Holdings
• Eurozone Business Activity Declines Amid Growing Concerns
• Analyzing the Biotech Sector's Recent Shift and Challenges
• USD/JPY Technical Analysis Amid Economic Developments
• Industrial Stocks with Impressive Dividends for Investors